HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of hydrogen sulfide in early blood-brain barrier disruption following transient focal cerebral ischemia.

Abstract
We determined the role of endogenous hydrogen sulfide (H2S) in cerebral vasodilation/hyperemia and early BBB disruption following ischemic stroke. A cranial window was prepared over the left frontal, parietal and temporal cortex in mice. Transient focal cerebral Ischemia was induced by directly ligating the middle cerebral artery (MCA) for two hours. Regional vascular response and cerebral blood flow (CBF) during ischemia and reperfusion were measured in real time. Early BBB disruption was assessed by Evans Blue (EB) and sodium fluorescein (Na-F) extravasation at 3 hours of reperfusion. Topical treatment with DL-propargylglycine (PAG, an inhibitor for cystathionine γ-lyase (CSE)) and aspartate (ASP, inhibitor for cysteine aminotransferase/3-mercaptopyruvate sulfurtransferase (CAT/3-MST)), but not O-(Carboxymethyl)hydroxylamine hemihydrochloride (CHH, an inhibitor for cystathionine β-synthase (CBS)), abolished postischemic cerebral vasodilation/hyperemia and prevented EB and Na-F extravasation. CSE knockout (CSE-/-) reduced postischemic cerebral vasodilation/hyperemia but only inhibited Na-F extravasation. An upregulated CBS was found in cerebral cortex of CSE-/- mice. Topical treatment with CHH didn't further alter postischemic cerebral vasodilation/hyperemia, but prevented EB extravasation in CSE-/- mice. In addition, L-cysteine-induced hydrogen sulfide (H2S) production similarly increased in ischemic side cerebral cortex of control and CSE-/- mice. Our findings suggest that endogenous production of H2S by CSE and CAT/3-MST during reperfusion may be involved in postischemic cerebral vasodilation/hyperemia and play an important role in early BBB disruption following transient focal cerebral ischemia.
AuthorsZheng Jiang, Chun Li, Morganne L Manuel, Shuai Yuan, Christopher G Kevil, Kimberly D McCarter, Wei Lu, Hong Sun
JournalPloS one (PLoS One) Vol. 10 Issue 2 Pg. e0117982 ( 2015) ISSN: 1932-6203 [Electronic] United States
PMID25695633 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Alkynes
  • Aspartic Acid
  • propargylglycine
  • Sulfurtransferases
  • 3-mercaptopyruvate sulphurtransferase
  • Cystathionine beta-Synthase
  • Cystathionine gamma-Lyase
  • Glycine
  • Hydrogen Sulfide
Topics
  • Alkynes (pharmacology)
  • Animals
  • Aspartic Acid (pharmacology)
  • Blood-Brain Barrier (drug effects, metabolism)
  • Cerebral Cortex (blood supply, metabolism)
  • Cystathionine beta-Synthase (antagonists & inhibitors, metabolism)
  • Cystathionine gamma-Lyase (antagonists & inhibitors, genetics, metabolism)
  • Glycine (analogs & derivatives, pharmacology)
  • Hydrogen Sulfide (metabolism)
  • Ischemic Attack, Transient (metabolism, pathology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Sulfurtransferases (antagonists & inhibitors, metabolism)
  • Vasodilation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: